top of page

Our leadership team has a proven track record across drug discovery, development and commercialization

Sue_Dillon Fall 2020 Vedanta Head Shot_e
Susan Dillon, PhD

Co-founder, President and Chief Executive Officer

Aro Biotherapeutics Karyn O’Neil, PhD.jp
Karyn O’Neil, PhD

Co-founder and Chief Scientific Officer

Aro Biotherapeutics Mitte Doyle.jpg
Mittie Doyle, MD, FACR

Chief Medical Officer

Aro Biotherapeutics Sukumar Sakamuri.jpg

Chief Technology Officer

ARO leadership Steve Nadler copy.jpg
Steven Nadler, PhD

Senior Vice President of Discovery and Translational Research

Aro Biotherapeutics Mark Laurenzi.jpg
Mark Laurenzi

Chief Administrative Officer & Vice President, Legal

Aro Biotherapeutics Jeffrey Staiger.jpg
Jeffrey Staiger

Senior Vice President of Finance and Business Development

Aro Biotherapeutics Adam Dinerman_.jpg
Adam Dinerman, PhD

Vice President of Chemistry, Manufacturing and Controls (CMC)

bottom of page